133 results on '"Mendonça BB"'
Search Results
2. Fatal Factitious Cushing’s Syndrome (Münchhausen’s Syndrome) in a Patient with a Prolactinoma and Silent Corticotrophinoma: Case Report and Literature Review
- Author
-
Gallucci-neto J, Machado Mc, Andrea Glezer, Lopes Lml, Fragoso Mcbv, Verduguez Eru, Albuquerque Eva, Bronstein, Gattaz Wf, Mendonça Bb, and Carlos André Minanni
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,medicine.disease ,Omics ,business ,Dermatology ,Prolactinoma - Published
- 2014
3. Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide
- Author
-
Batista RL and Mendonca BB
- Subjects
srd5a2 ,46 ,xy dsd ,differences of sexual development ,atypical genitalia ,dihydro-testosterone ,5α-reductase type 2 deficiency. ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Rafael Loch Batista, Berenice Bilharinho Mendonca Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clínicas, Disciplina de Endocrinologia, do Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilCorrespondence: Berenice Bilharinho Mendonca Eneas Carvalho de Aguiar, 255, São Paulo, SP 05403-000, BrazilTel +55 1126617512Email beremen@usp.brIntroduction: The conversion of testosterone into dihydrotestosterone is catalyzed by the 5α-reductase type 2 enzyme which plays a crucial role in the external genitalia virilization. It is encoded by the SRD5A2 gene. Allelic variants in this gene cause a 46,XY DSD with no genotype–phenotype relationship. It was firstly reported in the early 70s from isolated clusters. Since then, several cases have been reported. Putting together, it will expand the knowledge on the molecular bases of androgen milieu.Methods: We searched for SRD5A2 allelic variants (AV) in the literature (PubMed, Embase, MEDLINE) and websites (ensembl, HGMD, ClinVar). Only cases with AV in both alleles, either in homozygous or compound heterozygous were included. The included cases were analyzed according to ethnicity, exon, domain, aminoacid (aa) conservation, age at diagnosis, sex assignment, gender reassignment, external genitalia virilization and functional studies. External genitalia virilization was scored using Sinnecker scale. Conservation analysis was carried out using the CONSURF platform. For categorical variables, we used X2 test and Cramer’s V. Continuous variables were analyzed by t test or ANOVA. Concordance was estimated by Kappa.Results: We identified 434 cases of 5ARD2 deficiencies from 44 countries. Most came from Turkey (23%), China (17%), Italy (9%), and Brazil (7%). Sixty-nine percent were assigned as female. There were 70% of homozygous allelic variants and 30% compound heterozygous. Most were missense variants (76%). However, small indels (11%), splicing (5%) and large deletions (4%) were all reported. They were distributed along with all exons with exon 1 (33%) and exon 4 (25%) predominance. Allelic variants in the exon 4 (NADPH-binding domain) resulted in lower virilization (p< 0.0001). The codons 55, 65, 196, 235 and 246 are hotspots making up 25% of all allelic variants. Most of them (76%) were located at conserved aa. However, allelic variants at non-conserved aa were more frequently indels (28% vs 6%; p< 0.01). The overall rate of gender change from female to male ranged from 16% to 70%. The lowest rate of gender change from female to male occurred in Turkey and the highest in Brazil. External genitalia virilization was similar between those who changed and those who kept their assigned gender. The gender change rate was significantly different across the countries (V=0.44; p< 0.001) even with similar virilization scores.Conclusion: 5ARD2 deficiency has a worldwide distribution. Allelic variants at the NADPH-ligand region cause lower virilization. Genitalia virilization influenced sex assignment but not gender change which was influenced by cultural aspects across the countries. Molecular diagnosis influenced on sex assignment, favoring male sex assignment in newborns with 5α-reductase type 2 deficiency.Keywords: SRD5A2, 46XY DSD, differences of sexual development, atypical genitalia, dihydrotestosterone, 5α-reductase type 2 deficiency
- Published
- 2020
4. 17 Bèta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, pheontypic variability, population genetics, and worldwide distribution of ancient and de novo mutations
- Author
-
Boehmer, Annemie, Brinkmann, Albert, Ayuningtyas, Wireni, Halley, Dicky, Niermeijer, Martinus, Andersson, S, Jong, Frank, Kayserili, H, de Vroede, MA, Otten, BJ, Rouwé, CW, Mendonça, BB, Rodrigues, C, Bode, HH, Ruiter, Petra, Delemarre - van de Waal, H, Drop, Sten, Pediatrics, Developmental Biology, Epidemiology, and Clinical Genetics
- Published
- 1999
5. Circumscribed lesion of the medial forebrain bundle area causes structural impairment of lymphoid organs and severe depression of immune function in rats
- Author
-
Julio Licinio, K. I. Pasternak, Pozzi Dh, de Mendonça Bb, Rodrigues Cj, C Timo-iaria, L Paiva, Maria Da, Ma-Li Wong, and Duarte Aj
- Subjects
White pulp ,Cytotoxicity, Immunologic ,Male ,Cellular immunity ,Pathology ,medicine.medical_specialty ,Lymphoid Tissue ,T-Lymphocytes ,Spleen ,Thymus Gland ,Biology ,Lesion ,Cellular and Molecular Neuroscience ,Reference Values ,Cortex (anatomy) ,Weight Loss ,medicine ,Animals ,Rats, Wistar ,Medial forebrain bundle ,Molecular Biology ,Brain Mapping ,Medial Forebrain Bundle ,Germinal center ,Organ Size ,Rats ,Psychiatry and Mental health ,medicine.anatomical_structure ,Lymphatic system ,Female ,Lymph Nodes ,medicine.symptom ,Corticosterone - Abstract
Interactions between the immune system and the brain are a key element in the pathophysiology of diseases such as multiple sclerosis, neuroAIDS, and Alzheimer's, which affect large numbers of individuals and are associated with a high social cost. However, the neuroanatomical basis of brain-immune interactions has not been elucidated. We report that in Wistar rats of either sex bilateral electrolytic lesion of the medial forebrain bundle reduces body weight by 28% 7 days after lesioning, and causes widespread infections, aphagia, adypsia, structural damage to the lymphoid organs and heavy depression of T lymphocytes cytotoxicity. The following alterations occur in the immune system after those lesions: the weight of the thymus, spleen and lymphonodes is reduced by 77.9%, 49.1% and 48.4%, respectively. The thymus is atrophied and contains fewer lymphoid cells in the cortex than in the medulla. In the spleen the white pulp is reduced and lymphoid cells from periarteriolar zones and at the chords are almost absent. In lymph nodes cortical small lymphocytes are depleted and primary and secondary nodules and germinal centers all but disappear. Cytotoxicity of lymphocytes is reduced by 86.2% in the thymus, 77.6% in the spleen and 70.2% in lymph nodes. The critical area of lesion is at the medialmost portion of the medial forebrain bundle, at the preoptic area and rostral part of the anterior hypothalamus. We suggest that this area contains neural circuits that are crucial for keeping the structure of lymphoid organs and the functional integrity of the immune system.
- Published
- 1998
6. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations.
- Author
-
Pasoto, SG, Mendonça, BB, and Bonfá, E
- Subjects
- *
SYSTEMIC lupus erythematosus , *MENSTRUATION - Abstract
We have evaluated 36 consecutive systemic lupus erythematosus (SLE) female patients, age 18-39 years, without current or previous alkylating therapy, in order to determine the prevalence of the menstrual disturbances and their clinical, hormonal and therapeutic associations. Seventeen patients presented normal cycles, whereas menstrual alterations were observed in 19. Ovarian function was generally preserved in these groups. Sub-clinical thyroid disease (normal free T4 and elevated TSH) and slightly increased prolactin levels were detected in 8% of patients, with comparable frequencies in both groups. Similarly, the current use of azathioprine was not associated with menstrual disturbances. Percentages of prednisone current use (P=0.3), mean dose (P=0.062), and percentages of patients on high doses (≥30mg/day; P=0.09) were comparable in patients with or without menstrual alterations. In contrast, the mean SLEDAI levels (P=0.02) and the frequency of patients with SLEDAI ≥8 (P=0.008) were higher in patients with irregular cycles. Interestingly, 5/7 (71%) of the patients with menstrual disturbances and a new significant flare (SLEDAI ≥8) were evaluated before the introduction of high dose steroid, supporting the idea that disease activity is a major factor in menstrual disorders in SLE patients without alkylating therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
7. Renal Function Evolution and Hypoaldosteronism Risk After Unilateral Adrenalectomy for Primary Aldosteronism.
- Author
-
Queiroz NL, Stumpf MAM, Souza VCM, Maciel AAW, Fagundes GFC, Okubo J, Srougi V, Tanno FY, Chambo JL, Pereira MAA, Pio-Abreu A, Bortolotto LA, Latronico AC, Barisson Villares Fragoso MC, Drager LF, Mendonça BB, and Almeida MQ
- Subjects
- Humans, Female, Male, Middle Aged, Aldosterone blood, Adult, Risk Factors, Adrenalectomy adverse effects, Hyperaldosteronism surgery, Hyperaldosteronism etiology, Hyperaldosteronism physiopathology, Glomerular Filtration Rate, Hypoaldosteronism etiology, Hypoaldosteronism physiopathology, Kidney physiopathology
- Abstract
Few studies demonstrated a percentage decrease in the estimated glomerular filtration rate (eGFR) at a single time and the rate of hypoaldosteronism after adrenalectomy for primary aldosteronism (PA). Our aim was to investigate the evolution of renal function and the hypoaldosteronism risk after adrenalectomy for PA. Aldosterone, renin, eGFR, and electrolyte levels were determined before and at 1 week, 1, 3 and 6 months after unilateral adrenalectomy in 94 PA patients (40 men and 54 women). The main outcome was the postoperative eGFR decline using analysis of covariance with the preoperative eGFR as a covariate. eGFR decreased during first postoperative week compared to 3 months before surgery. During the first 6 months, eGFR remained stable at similar levels to the first week after surgery. Age (p=0.001), aldosterone levels (p=0.021) and eGFR 3 months before surgery (p+<+0.0001) had a significant correlation with eGFR during first postoperative week. High aldosterone levels at diagnosis were correlated with decline in renal function in the univariate model (p=0.033). In the multivariate analysis, aldosterone levels at diagnosis had a tendency to be an independent predictor of renal function after surgery (p=0.059). Postoperative biochemical hypoaldosteronism was diagnosed in 48% of the cases after adrenalectomy, but prolonged hyperkalemia occurred in only 4 cases (4.5%). Our findings showed a decrease of eGFR after unilateral adrenalectomy for PA. Additionally, aldosterone levels at diagnosis correlated with postoperative renal function. Postoperative biochemical hypoaldosteronism occurred in almost half of the patients, but prolonged hyperkalemia with fludrocortisone replacement was less frequent., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Homozygous CDH2 variant may be associated with hypopituitarism without neurological disorders.
- Author
-
Ferreira NGBP, Madeira JLO, Gergics P, Kertsz R, Marques JM, Trigueiro NSS, Benedetti AFF, Azevedo BV, Fernandes BHV, Bissegatto DD, Biscotto IP, Fang Q, Ma Q, Ozel AB, Li J, Camper SA, Jorge AAL, Mendonça BB, Arnhold IJP, and Carvalho LR
- Abstract
Context: Congenital hypopituitarism is a genetically heterogeneous condition. Whole exome sequencing (WES) is a promising approach for molecular diagnosis of patients with this condition., Objectives: The aim of this study is to conduct WES in a patient with congenital hypopituitarism born to consanguineous parents, CDH2 screening in a cohort of patients with congenital hypopituitarism, and functional testing of a novel CDH2 variant., Design: Genomic DNA from a proband and her consanguineous parents was analyzed by WES. Copy number variants were evaluated. The genetic variants were filtered for population frequency (ExAC, 1000 genomes, gnomAD, and ABraOM), in silico prediction of pathogenicity, and gene expression in the pituitary and/or hypothalamus. Genomic DNA from 145 patients was screened for CDH2 by Sanger sequencing., Results: One female patient with deficiencies in growth hormone, thyroid-stimulating hormone, adrenocorticotropic hormone, luteinizing hormone, and follicle-stimulating hormone and ectopic posterior pituitary gland contained a rare homozygous c.865G>A (p.Val289Ile) variant in CDH2. To determine whether the p.Val289Ile variant in CDH2 affects cell adhesion properties, we stably transfected L1 fibroblast lines, labeled the cells with lipophilic dyes, and quantified aggregation. Large aggregates formed in cells expressing wildtype CDH2, but aggregation was impaired in cells transfected with variant CDH2 or non-transfected., Conclusion: A homozygous CDH2 allelic variant was found in one hypopituitarism patient, and the variant impaired cell aggregation function in vitro. No disease-causing variants were found in 145 other patients screened for CDH2 variants. Thus, CDH2 is a candidate gene for hypopituitarism that needs to be tested in different populations., Significance Statement: A female patient with hypopituitarism was born from consanguineous parents and had a homozygous, likely pathogenic, CDH2 variant that impairs cell aggregation in vitro. No other likely pathogenic variants in CDH2 were identified in 145 hypopituitarism patients.
- Published
- 2023
- Full Text
- View/download PDF
9. Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy.
- Author
-
Cunha FS, Bachega TASS, Costa EMF, Brito VN, Alvares LA, Costa-Hong VA, Verardino RGS, Sircili MHP, de Mendonça BB, Bortolotto LA, and Domenice S
- Abstract
Context: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment., Objective: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid-femoral pulse wave velocity (cf-PWV)., Methods: A cross-sectional case-control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 ± 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group., Results: The cf-PWV after long-term testosterone therapy was significantly higher in TM (7.4 ± 0.9 m/s; range 5.8-8.9 m/s) than in cisgender men (6.6 ± 1.0 m/s; range 3.8-9.0 m/s, P < .01) and cisgender women controls (6.9 ± .9 m/s; range 4.8-9.1 m/s, P = .02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group., Conclusion: The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended., (© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.)
- Published
- 2023
- Full Text
- View/download PDF
10. Cardiopulmonary capacity and muscle strength in transgender women on long-term gender-affirming hormone therapy: a cross-sectional study.
- Author
-
Alvares LAM, Santos MR, Souza FR, Santos LM, Mendonça BB, Costa EMF, Alves MJNN, and Domenice S
- Subjects
- Male, Female, Humans, Adult, Cross-Sectional Studies, Hand Strength, Muscle Strength, Hormones, Transgender Persons
- Abstract
Objective: For transgender women (TW) on oestrogen therapy, the effects of prior exposure to testosterone during puberty on their performance, mainly cardiopulmonary capacity (CPC), while exerting physical effort are unknown. Our objective was to evaluate CPC and muscle strength in TW undergoing long-term gender-affirming hormone therapy., Methods: A cross-sectional study was carried out with 15 TW (34.2±5.2 years old), 13 cisgender men (CM) and 14 cisgender women (CW). The TW received hormone therapy for 14.4±3.5 years. Bioimpedance, the hand grip test and cardiopulmonary exercise testing on a treadmill with an incremental effort were performed., Results: The mean VO2peak (L/min) was 2606±416.9 in TW, 2167±408.8 in CW and 3358±436.3 in CM (TW vs CW, p<0.05; TW vs CM, p<0.0001; CW vs CM, p<0.0001). The O2 pulse in TW was between that in CW and CM (TW vs CW, p<0.05, TW vs CM, p<0.0001). There was a high correlation between VO2peak and fat-free mass/height
2 among TW (r=0.7388; p<0.01), which was not observed in the other groups. The mean strength (kg) was 35.3±5.4 in TW, 29.7±3.6 in CW and 48.4±6.7 in CM (TW vs CW, p<0.05; TW vs CM, p<0.0001)., Conclusion: CPC in non-athlete TW showed an intermediate pattern between that in CW and CM. The mean strength and VO2 peak in non-athlete TW while performing physical exertion were higher than those in non-athlete CW and lower than those in CM., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2022
- Full Text
- View/download PDF
11. Impact of schooling in the HIV/AIDS prevalence among Brazilian transgender women.
- Author
-
Batista RL, Verduguez EDR, Inacio M, Cunha FS, Marques MD, Gomes NLRA, Faria JAD Jr, Sircili MHP, Mendonça BB, Costa EMF, and Domenice S
- Subjects
- Adolescent, Brazil, Cross-Sectional Studies, Female, HIV, Humans, Male, Prevalence, Young Adult, HIV Infections, Transgender Persons
- Abstract
Objective Discrimination and bullying are common conditions among LGBT people. During schooling, these practices compromising education. The aim of this study is to evaluate educational attainment among Brazilian transgender women (TW) and how their education level affects the risk of HIV infection. Study design a cross-sectional population-based study. Subjects and methods 95 adult TW were selected. Information concerning verbal and physical aggression, school dropout, school years (SY), and educational level were assessed. HIV status was screened using a fourth-generation immunoassay followed by western blot testing. Results The mean of SY was 9.1 ± 3.8 ys. The mean age at school dropout was 16.3 ± 3.4 ys old. Verbal aggression was reported by 83%, physical by 48%, and 18% of the TW dropped out school immediately after being physically assaulted. Participants who suffered physical aggression attended school for almost 4 years less than those participants who did not suffer this abuse (OR = -3.96, p < 0.0001). A similar result was found for verbal aggression (OR = -4.35; p < 0.0001). HIV/AIDS prevalence was 18% (n = 17). The mean of SY among HIV/AIDS positive and negative individuals were 6.8 ± 43 versus 9.7 ± 3, respectively (p = 0.004). Lower education was associated with higher frequency of HIV/AIDS among TW and this relationship was sustained after adjustment for injectable drug use and sex work (OR = 0.79, p = 0.04). Conclusion Among Brazilian TW, lower education level was a risk factor associated with HIV. The reasons for low schooling among TW are multifactorial, but verbal and physical harassment strongly contribute for it.
- Published
- 2020
- Full Text
- View/download PDF
12. Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years.
- Author
-
Iervolino LL, Ferraz-de-Souza B, Martin RM, Costa FC, Miranda MC, Mendonça BB, and Bachega TS
- Subjects
- Absorptiometry, Photon, Adult, Child, Glucocorticoids adverse effects, Humans, Retrospective Studies, Young Adult, Adrenal Hyperplasia, Congenital drug therapy, Bone Density
- Abstract
The congenital adrenal hyperplasia population seems to have an intrinsic tendency to a high frequency of low bone mass. However in this single-center and long-term evaluated cohort, the simplified corticoid regimen, with exclusive dexamethasone single dose reposition during adulthood, did not represent a risk factor for decrease in bone health., Introduction: The impact of long-term and supposedly physiological doses of gluco and mineralocorticoid (GC/MC) on bone mineral density (BMD) in congenital adrenal hyperplasia (CAH) remains discordant among studies, which contain different clinical forms and corticoid regimens. Our aim was to evaluate the BMD in CAH adults receiving similar GC regimen since childhood and to correlate it with GC/MC cumulative doses., Methods: Only patients with good compliance, who used cortisone acetate (CA) during childhood and dexamethasone after the final height achievement. Cumulative GC/MC doses were calculated from diagnosis until last evaluation. BMD was analyzed by the first and last energy X-ray absorptiometry (DXA) scans performed., Results: Twenty simple virilizing (SV) and 14 salt wasting (WS) whose mean age was 26 ± 6 years, mean CA, dexamethasone, and fludrocortisone cumulative doses were 63,813 ± 32,767, 812 ± 558, and 319 ± 325 mg/m
2 , respectively. Based on the last DXA, low BMD was observed in 11% of patients, total hip Z-score was lower in the SW than SV form (p = 0.04). Cumulative CA dose had an inverse correlation with femoral neck Z-score (p < 0.01). Total cumulative GC and MC doses had an inverse correlation with total hip Z-score (p < 0.01). In the analysis of sequential BMD during dexamethasone therapy, no association was observed among cumulative GC/MC doses, clinical forms, sex, and lumbar Z-score delta., Conclusions: Even though a low CA regimen during growth periods in addition to MC replacement appears to have an influence on BMD at femoral sites, interestingly a low dexamethasone one does not seem to be deleterious for bone health in adulthood.- Published
- 2020
- Full Text
- View/download PDF
13. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
- Author
-
Inoue-Lima TH, Vasques GA, Nakaguma M, Brito LP, Mendonça BB, Arnhold IJP, and Jorge AAL
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Male, Retrospective Studies, Growth Disorders blood, Growth Disorders diagnosis, Human Growth Hormone deficiency, Insulin-Like Growth Factor Binding Protein 3 blood, Insulin-Like Growth Factor I metabolism
- Abstract
Background: The utility of insulin-like growth factor type 1 (IGF-1) is well established in the diagnosis of growth hormone deficiency (GHD), whereas IGF-binding protein type 3 (IGFBP-3) has a more controversial role. Most studies evaluated the value of these peptides by assessing their sensitivity and specificity but not considering the low prevalence of GHD among short children (<2%)., Objective: To evaluate the utility of basal IGF-1 and IGFBP-3 values in the GHD diagnosis process with a Bayesian approach, based on pre- and post-test probability., Methods: We determined ROC curves, sensitivity, specificity, and positive and negative predictive values for IGF-1 and IGFBP-3 obtained from patients with GHD (n = 48) and GH-sufficient children (n = 175). The data were also analyzed by classifying the children into early childhood and late childhood (girls and boys younger and older than 8 and 9 years, respectively)., Results: The area under the curve (AUC) of the receiver operating characteristic curve of IGF-1-SDS (standard deviation score) was greater than that of IGFBP-3-SDS (AUC 0.886 and 0.786, respectively, p = 0.001). In early childhood, the AUC of IGFBP-3-SDS was significantly improved (0.866) and similar to IGF-1-SDS (0.898). IGF-1-SDS, in comparison to IGFBP-3-SDS, had a greater sensitivity (92 vs. 45.8%, respectively), lower specificity (69 vs. 93.8%, respectively), and lower positive predictive value (5.7 vs. 13.1%, respectively), with similar negative predictive values., Conclusion: IGF-1-SDS is a useful screening tool in the diagnosis of GHD. Although IGFBP-3-SDS lacks sensitivity, its high specificity supports the role to confirm GHD in short children, especially in early childhood. This strategy could simplify and reduce the necessity of a second laborious and expensive GH stimulation test to confirm the diagnosis of GHD., (© 2020 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
14. Combined pituitary hormone deficiency caused by PROP1 mutations: update 20 years post-discovery.
- Author
-
Correa FA, Nakaguma M, Madeira JLO, Nishi MY, Abrão MG, Jorge AAL, Carvalho LR, Arnhold IJP, and Mendonça BB
- Subjects
- Female, Humans, Hypopituitarism diagnosis, Male, Phenotype, Septo-Optic Dysplasia genetics, Homeodomain Proteins genetics, Hypopituitarism genetics, Mutation genetics
- Abstract
The first description of patients with combined pituitary hormone deficiencies (CPHD) caused by PROP1 mutations was made 20 years ago. Here we updated the clinical and genetic characteristics of patients with PROP1 mutations and summarized the phenotypes of 14 patients with 7 different pathogenic PROP1 mutations followed at the Hospital das Clínicas of the University of Sao Paulo. In addition to deficiencies in GH, TSH, PRL and gonadotropins some patients develop late ACTH deficiency. Therefore, patients with PROP1 mutations require permanent surveillance. On magnetic resonance imaging, the pituitary stalk is normal, and the posterior lobe is in the normal position. The anterior lobe in patients with PROP1 mutations is usually hypoplastic but may be normal or even enlarged. Bi-allelic PROP1 mutations are currently the most frequently recognized genetic cause of CPHD worldwide. PROP1 defects occur more frequently among offspring of consanguineous parents and familial cases, but they also occur in sporadic cases, especially in countries in which the prevalence of PROP1 mutations is relatively high. We classified all reported PROP1 variants described to date according to the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG-AMP) guidelines: 29 were pathogenic, 2 were likely pathogenic, and 2 were of unknown significance. An expansion of the phenotype of patients with PROP1 mutations was observed since the first description 20 years ago: variable anterior pituitary size, different pathogenic mutations, and late development of ACTH deficiency. PROP1 mutations are the most common cause of autosomal recessive CPHD with a topic posterior pituitary lobe. Arch Endocrinol Metab. 2019;63(2):167-74.
- Published
- 2019
- Full Text
- View/download PDF
15. Primary malignant tumors of the adrenal glands.
- Author
-
Almeida MQ, Bezerra-Neto JE, Mendonça BB, Latronico AC, and Fragoso MCBV
- Subjects
- Adrenal Cortex Neoplasms diagnosis, Adrenal Cortex Neoplasms pathology, Adrenal Gland Neoplasms diagnosis, Adrenal Gland Neoplasms pathology, Adrenocortical Carcinoma diagnosis, Adrenocortical Carcinoma pathology, Antineoplastic Agents, Hormonal therapeutic use, Humans, Mitotane therapeutic use, Paraganglioma diagnosis, Paraganglioma pathology, Pheochromocytoma diagnosis, Pheochromocytoma pathology, Adrenal Cortex Neoplasms therapy, Adrenal Gland Neoplasms therapy, Adrenocortical Carcinoma therapy, Paraganglioma therapy, Pheochromocytoma therapy
- Abstract
Malignancy must be considered in the management of adrenal lesions, including those incidentally identified on imaging studies. Adrenocortical carcinomas (ACCs) are rare tumors with an estimated annual incidence of 0.7-2 cases per year and a worldwide prevalence of 4-12 cases per million/year. However, a much higher incidence of these tumors (>15 times) has been demonstrated in south and southeastern Brazil. Most ACCs cause hypersecretion of steroids including glucocorticoids and androgens. ACC patients have a very poor prognosis with a 5-year overall survival (OS) below 30% in most series. Pheochromocytoma or paraganglioma (PPGL) is a metabolically active tumor originating from the chromaffin cells of the adrenal medulla. The incidence of PPGL is 0.2 to 0.9 cases per 100,000 individuals per year. Pheochromocytomas are present in approximately 4-7% of patients with adrenal incidentalomas. Classically, PPGL manifests as paroxysmal attacks of the following 4 symptoms: headaches, diaphoresis, palpitations, and severe hypertensive episodes. The diagnosis of malignant PPGL relies on the presence of local invasion or metastasis. In this review, we present the clinical and biochemical characteristics and pathogenesis of malignant primary lesions that affect the cortex and medulla of human adrenal glands.
- Published
- 2018
- Full Text
- View/download PDF
16. An update of genetic basis of PCOS pathogenesis.
- Author
-
Crespo RP, Bachega TASS, Mendonça BB, and Gomes LG
- Subjects
- Female, Humans, Phenotype, Polycystic Ovary Syndrome genetics
- Abstract
Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder that affects 5-20% of reproductive age women. PCOS clinical symptoms include hirsutism, menstrual dysfunction, infertility, obesity and metabolic syndrome. There is a wide heterogeneity in clinical manifestations and metabolic complications. The pathogenesis of PCOS is not fully elucidated, but four aspects seem to contribute to the syndrome to different degrees: increased ovarian and/or adrenal androgen secretion, partial folliculogenesis arrest, insulin resistance and neuroendocrine axis dysfunction. A definitive etiology remains to be elucidated, but PCOS has a strong heritable component indicated by familial clustering and twin studies. Genome Wide Association Studies (GWAS) have identified several new risk loci and candidate genes for PCOS. Despite these findings, the association studies have explained less than 10% of heritability. Therefore, we could speculate that different phenotypes and subphenotypes are caused by rare private genetic variants. Modern genetic studies, such as whole exome and genome sequencing, will help to clarify the contribution of these rare genetic variants on different PCOS phenotypes. Arch Endocrinol Metab. 2018;62(3):352-61.
- Published
- 2018
- Full Text
- View/download PDF
17. Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: Are we offering the best?
- Author
-
Srougi V, de Bessa J Jr, Tanno FY, Ferreira AM, Hoff AO, Bezerra JE, Almeida CM, Almeida MQ, Mendonça BB, Nahas WC, Chambô JL, Srougi M, and Fragoso MCBV
- Subjects
- Adrenal Cortex Neoplasms surgery, Adrenalectomy, Adrenocortical Carcinoma surgery, Adult, Aged, Aged, 80 and over, Case-Control Studies, Disease-Free Survival, Female, Follow-Up Studies, Humans, Male, Middle Aged, Radiotherapy, Adjuvant methods, Retrospective Studies, Young Adult, Adrenal Cortex Neoplasms radiotherapy, Adrenocortical Carcinoma radiotherapy
- Abstract
Purpose: To evaluate the role of ARDT after surgical resection of ACC., Materials and Methods: Records of patients from our institutional ACC database were retrospectively assessed. A paired comparison analysis was used to evaluate the oncological outcomes between patients treated with surgery followed by ARDT or surgery only (control). The endpoints were LRFS, RFS, and OS. A systematic review of the literature and meta-analysis was also performed to evaluate local recurrence of ACC when ARDT was used., Results: Ten patients were included in each Group. The median follow-up times were 32 months and 35 months for the ARDT and control Groups, respectively. The results for LRFS (p=0.11), RFS (p=0.92), and OS (p=0.47) were similar among subsets. The mean time to present with local recurrence was significantly longer in the ARDT group compared with the control Group (419±206 days vs. 181±86 days, respectively; p=0.03). ARDT was well tolerated by the patients; there were no reports of late toxicity. The meta-analysis, which included four retrospective series, revealed that ARDT had a protective effect on LRFS (HR=0.4; CI=0.17-0.94)., Conclusions: ARDT may reduce the chance and prolong the time to ACC local recurrence. However, there were no benefits for disease recurrence control or overall survival for patients who underwent this complementary therapy., Competing Interests: Conflict of interest: None declared., (Copyright® by the International Brazilian Journal of Urology.)
- Published
- 2017
- Full Text
- View/download PDF
18. Non-coding variation in disorders of sex development.
- Author
-
Baetens D, Mendonça BB, Verdin H, Cools M, and De Baere E
- Subjects
- Animals, Disorders of Sex Development diagnosis, Disorders of Sex Development pathology, Forkhead Box Protein L2, Forkhead Transcription Factors genetics, Gene Expression Regulation, Developmental, Gonads growth & development, Gonads pathology, Humans, Mutation, SOX9 Transcription Factor genetics, Sex-Determining Region Y Protein genetics, Steroidogenic Factor 1 genetics, Chromatin genetics, Disorders of Sex Development genetics, Pathology, Molecular, Regulatory Sequences, Nucleic Acid genetics
- Abstract
Genetic studies in Disorders of Sex Development (DSD), representing a wide spectrum of developmental or functional conditions of the gonad, have mainly been oriented towards the coding genome. Application of genomic technologies, such as whole-exome sequencing, result in a molecular genetic diagnosis in ∼50% of cases with DSD. Many of the genes mutated in DSD encode transcription factors such as SRY, SOX9, NR5A1, and FOXL2, characterized by a strictly regulated spatiotemporal expression. Hence, it can be hypothesized that at least part of the missing genetic variation in DSD can be explained by non-coding mutations in regulatory elements that alter gene expression, either by reduced, mis- or overexpression of their target genes. In addition, structural variations such as translocations, deletions, duplications or inversions can affect the normal chromatin conformation by different mechanisms. Here, we review non-coding defects in human DSD phenotypes and in animal models. The wide variety of non-coding defects found in DSD emphasizes that the regulatory landscape of known and to be discovered DSD genes has to be taken into consideration when investigating the molecular pathogenesis of DSD., (© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
19. Heterozygous Nonsense Mutation in the Androgen Receptor Gene Associated with Partial Androgen Insensitivity Syndrome in an Individual with 47,XXY Karyotype.
- Author
-
Batista RL, Rodrigues AS, Nishi MY, Feitosa ACR, Gomes NLRA, Junior JAF, Domenice S, Costa EMF, and de Mendonça BB
- Subjects
- Base Sequence, Exons genetics, Female, Heterozygote, Homozygote, Humans, Male, Microsatellite Repeats genetics, Young Adult, Androgen-Insensitivity Syndrome genetics, Codon, Nonsense genetics, Genetic Predisposition to Disease, Karyotype, Mutation genetics, Receptors, Androgen genetics
- Abstract
There are only 2 patients with 47,XXY karyotype and androgen receptor (AR) gene mutation reported in the literature, and both are diagnosed as complete androgen insensitivity syndrome (CAIS). We report a 22-year-old female with 47,XXY karyotype and atypical external genitalia. Sequencing of AR revealed the heterozygous p.Asn849Lys*32 mutation, and extensive X chromosome microsatellite analysis showed homozygosity for Xp and heterozygosity for Xq, suggesting partial X maternal isodisomy. Partial androgen insensitivity syndrome (PAIS) developed in this case, probably because of the presence of the heterozygous AR mutation and random X- inactivation of the healthy allele. This is the first report of a female patient with 47,XXY karyotype and PAIS phenotype., (© 2017 S. Karger AG, Basel.)
- Published
- 2017
- Full Text
- View/download PDF
20. A Novel Homozygous Missense FSHR Variant Associated with Hypergonadotropic Hypogonadism in Two Siblings from a Brazilian Family.
- Author
-
França MM, Lerario AM, Funari MFA, Nishi MY, Narcizo AM, de Mello MP, Guerra-Junior G, Maciel-Guerra AT, and Mendonça BB
- Subjects
- Adolescent, Adult, Base Sequence, Brazil, Family, Female, Homozygote, Humans, Male, Pedigree, Exome Sequencing, Hypogonadism genetics, Mutation, Missense genetics, Receptors, FSH genetics, Siblings
- Abstract
Hypergonadotropic hypogonadism (HH) is defined by increased gonadotropin levels in men and women. Primary ovarian failure (POF) is a form of female infertility characterized by amenorrhea, hypoestrogenism, and elevated gonadotropin levels in women under the age of 40 years. Although several genes have been associated with POF, its causative genes remain to be identified. Here, we used whole-exome sequencing (WES) to study a consanguineous family with a 46,XX girl and a 46,XY man affected by HH. All exons of both siblings and their parents were captured and massively sequenced by WES, and the candidate variant was confirmed by Sanger sequencing. A novel c.1298C>A;p.Ala433Asp missense variant of the follicle-stimulating hormone receptor (FSHR) gene was found in both affected siblings in a homozygous state and in their parents in a heterozygous state. This FSHR variant is not present in available databases (1000 Genomes and NHLBI/EVS) and Brazilian exome controls. Moreover, it is highly conserved and predicted as deleterious in all prediction sites analyzed. In conclusion, the novel homozygous FSHR variant observed in 2 siblings with HH can expand the spectrum of FSHR mutations in humans., (© 2017 S. Karger AG, Basel.)
- Published
- 2017
- Full Text
- View/download PDF
21. Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.
- Author
-
Machado MC, Alcantara AE, Pereira AC, Cescato VA, Castro Musolino NR, de Mendonça BB, Bronstein MD, and Fragoso MC
- Subjects
- Adenoma etiology, Adenoma pathology, Adolescent, Adult, Aged, Child, Enzyme-Linked Immunosorbent Assay, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Recurrence, Local, Pituitary ACTH Hypersecretion physiopathology, Pituitary Neoplasms etiology, Pituitary Neoplasms pathology, Retrospective Studies, Young Adult, Adenoma blood, Adrenocorticotropic Hormone blood, Hydrocortisone blood, Pituitary ACTH Hypersecretion complications, Pituitary Neoplasms blood
- Abstract
Purpose: Pituitary macroadenomas (MACs) represent 10-30 % of Cushing's disease (CD) cases. The aim of this study was to report the clinical, laboratorial and imaging features and postsurgical outcomes of microadenoma (MIC) and MAC patients., Methods: Retrospective study with 317 CD patients (median 32 years old, range 9-71 years) admitted between 1990 and 2014, 74 (23.3 %) of whom had MAC., Results: Hirsutism, plethora facial, muscular weakness and muscular atrophy were more frequent in the MIC patients. Nephrolithiasis, osteopenia, hyperprolactinaemia and galactorrhoea were more prevalent in MAC patients. The morning serum cortisol (Fs), nocturnal salivary cortisol (NSC), nocturnal Fs (Fs 2400 h), low- and high-dose dexamethasone suppression test results and CRH and desmopressin test results were similar between the subgroups. MIC patients showed higher urinary cortisol at 24 h (UC), and MAC patients presented higher ACTH levels but lower Fs/ACTH, Fs 2400 h/ACTH, NSC/ACTH and UC/ACTH ratios. There were negative correlations of tumour size with Fs/ACTH, Fs 2400 h/ACTH, NSC/ACTH and UC/ACTH ratios. Overall, the postsurgical remission and recurrence rates were similar between MIC and MAC. However, patients in remission (MIC + MAC) showed smaller tumour diameters and a lower prevalence of invasion and extension on MRI., Conclusions: Despite exhibiting higher plasma ACTH levels, CD patients with MAC presented lower cortisol/ACTH ratios than did patients with MIC, with a negative correlation between tumour size and cortisol/ACTH ratios. The overall postsurgical remission and recurrence rates were similar between MIC and MAC patients, with those with larger and/or invasive tumours showing a lower remission rate.
- Published
- 2016
- Full Text
- View/download PDF
22. The Use of Three-dimensional Printers for Partial Adrenalectomy: Estimating the Resection Limits.
- Author
-
Srougi V, Rocha BA, Tanno FY, Almeida MQ, Baroni RH, Mendonça BB, Srougi M, Fragoso MC, and Chambô JL
- Subjects
- Aged, Humans, Hyperplasia surgery, Male, Organ Size, Adrenal Gland Diseases surgery, Adrenal Glands pathology, Adrenalectomy methods, Printing, Three-Dimensional
- Abstract
Objective: To avoid hormonal replacement after partial adrenalectomy (PA), establishing the precise limit of an adrenal gland resection is essential. Herein, we evaluated the use of three-dimensional (3D) adrenal gland printing and volumetry measurement before PA to improve the determination of the remnant gland volume., Methods: Concomitant total adrenalectomy and a contralateral PA were performed in a patient with primary macronodular adrenal hyperplasia that exhibited mild hypercortisolism, arterial hypertension, and diabetes. Before surgery, a 3D replica of the adrenal gland to be partially resected was printed and given to the surgeon. The volumetry of the gland was measured by computed tomography 3D image reconstruction., Results: No postoperative complications were noted. Immediately after the surgery, the patient initiated corticosteroid replacement, which was interrupted 52 days later. At the 6-month follow-up, the patient stopped using medications for diabetes and reduced the number of antihypertensive medications from 5 to 1. The pre- and postoperative serum cortisol levels were, respectively, 28 and 8.7 mcg/dl (n 5-25 mcg/dl). The pre- and postoperative adrenocorticotropic hormone levels were, respectively, <5 and 88 pg/ml (n 7.2-63 pg/ml). The postoperative adrenal volume was 12% of the total preoperative adrenal volume., Conclusion: The use of 3D printing associated with adrenal volumetry might be a useful tool for the surgeon when performing PA, enabling an estimation of the remnant gland volume., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
23. Retraction Note: Fatal factitious Cushing syndrome (Münchhausen's syndrome) in a patient with macroprolactinoma and silent corticotrophinoma: case report and literature review.
- Author
-
Minanni CA, Cardoso ALA, Albuquerque EVA, Brito LP, Lopes LML, Glezer A, Verduguez EDRU, De Mendonça BB, Bronstein MD, Machado MC, and Fragoso MCBV
- Abstract
[This retracts the article DOI: 10.1186/s40842-015-0002-8.].
- Published
- 2016
- Full Text
- View/download PDF
24. Malignant paraganglioma in children treated with embolization prior to surgical excision.
- Author
-
de Paula Miranda E, Lopes RI, Padovani GP, Moscardi PR, Nishimura FG, de Mendonça BB, Carnevale FC, Cristofani LM, Duarte RJ, Srougi M, and Denes FT
- Subjects
- Adolescent, Adult, Child, Humans, Male, Paraganglioma pathology, Preoperative Care, Prognosis, Embolization, Therapeutic adverse effects, Paraganglioma etiology, Pelvic Neoplasms therapy
- Abstract
Background: Paragangliomas (PGL) are rare tumors derived from neural crest cells, whose origins may vary along the chain of the sympathetic nervous system. Such tumors are often characterized by secretion of catecholamines, but sometimes they are biochemically inactive, which makes diagnosis often challenging. Malignant paraganglioma is defined by the presence of this tumor at sites where chromaffin cells are usually not found or by local invasion of the primary tumor. Recurrence, either regional or metastatic, usually occurs within 5 years of the initial complete resection but long-term recurrence is also described. Malignancy is often linked to a SDHB mutation. Preoperative embolization has been applied in the surgical management of PGLs with the objective to decrease intra-operative blood loss and surgery length without complications., Case Presentation: We report two cases of patients with abdominal or pelvic malignant PGLs who have been treated surgically at our center after preoperative embolization. Surgery was a very challenging procedure with multiple surgical teams involved and embolization did not prevent major blood loss and intraoperative complications. Patients required adjuvant treatment with either chemotherapy or radiotherapy., Conclusions: Many studies in the adult population have established recommendations for the diagnosis and therapeutic management of PGL, but few studies concern the pediatric population. Because malignant PGL is more important in the pediatric population, screening and early diagnosis of PGL is advisable in children with genetic predisposing. Surgical resection is the mainstay of treatment, but a multimodal approach is often required due to the complexity of cases. The role of preoperative embolization is not established and in our experience it has provided little benefit and major complications.
- Published
- 2016
- Full Text
- View/download PDF
25. Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy.
- Author
-
Cunha FS, Domenice S, Câmara VL, Sircili MH, Gooren LJ, Mendonça BB, and Costa EM
- Subjects
- Adult, Antineoplastic Agents therapeutic use, Cabergoline, Ergolines therapeutic use, Estrogens therapeutic use, Female, Humans, Magnetic Resonance Imaging, Male, Pituitary Neoplasms chemically induced, Pituitary Neoplasms drug therapy, Prolactin blood, Prolactinoma chemically induced, Prolactinoma drug therapy, Estrogens adverse effects, Pituitary Neoplasms diagnosis, Prolactinoma diagnosis, Transgender Persons
- Abstract
Male-to-female transsexual persons use oestrogens + antiandrogens to adapt their physical bodies to the female sex. Doses are usually somewhat higher than those used by hypogonadal women receiving oestrogen replacement. Particularly in cases of self-administration of cross-sex hormones, doses may be very high. Oestrogens are powerful stimulators of synthesis and release of prolactin and serum prolactin levels are usually somewhat increased following oestrogen treatment. Prolactinomas have been reported in male-to-female transsexual persons, both after use of high and conventional doses of oestrogens but remain rare events. We report two new cases of prolactinomas in male-to-female transsexual persons, one in a 41-year-old subject who had used nonsupervised high-dose oestrogen treatment since the age of 23 years and another one in a 42 year old who had initiated oestrogen treatment at the age of 17 years. Their serum prolactin levels were strongly increased, and the diagnosis of a pituitary tumour was confirmed by imaging techniques. Both cases responded well to treatment with cabergoline treatment whereupon serum prolactin normalised. Our two cases are added to the three cases of prolactinomas in the literature in persons who had used supraphysiological doses of oestrogens., (© 2014 Blackwell Verlag GmbH.)
- Published
- 2015
- Full Text
- View/download PDF
26. RETRACTED ARTICLE: Fatal factitious Cushing syndrome (Münchhausen's syndrome) in a patient with macroprolactinoma and silent corticotrophinoma: case report and literature review.
- Author
-
Minanni CA, De Almeida Cardoso AL, de Albuquerque Albuquerque EV, Brito LP, Lopes LML, Glezer A, Verduguez EDRU, De Mendonça BB, Bronstein MD, Machado MC, and Fragoso MCBV
- Abstract
Münchhausen's syndrome (MS) is a chronic factitious disorder characterized by the intentional production of clinical symptoms without external incentive. One type of MS is factitious Cushing syndrome, an extremely rare clinical situation in which the diagnosis is challenging mainly due to interference of the exogenous medication in cortisol immunoassays. We described a 26-year-old woman who was originally diagnosed with a macroprolactinoma and during follow-up developed clinical and laboratorial hypercortisolism. A transsphenoidal surgery was performed and immunohistochemistry revealed positive and diffuse staining for both hormones. Four years later, her hypercortisolism recurred and the confirmation of factitious Cushing syndrome was delayed due to conflicting laboratorial results. There are few cases in the literature of factitious Cushing syndrome, and only one had a fatal outcome. The diagnosis of this condition is complex and includes cyclic Cushing syndrome in the differential diagnosis. These patients have high morbidity and increased mortality risk and are likely to have other psychiatric disorders. Prednisone was identified as the culprit in the majority of the cases.
- Published
- 2015
- Full Text
- View/download PDF
27. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency.
- Author
-
Khattab A, Yuen T, Yau M, Domenice S, Frade Costa EM, Diya K, Muhuri D, Pina CE, Nishi MY, Yang AC, de Mendonça BB, and New MI
- Subjects
- 17-Hydroxysteroid Dehydrogenases chemistry, 17-Hydroxysteroid Dehydrogenases genetics, Amino Acid Sequence, Child, Chromatography, High Pressure Liquid, Female, Humans, Male, Molecular Sequence Data, Pedigree, Polymorphism, Single Nucleotide, Sequence Homology, Amino Acid, Tandem Mass Spectrometry, 17-Hydroxysteroid Dehydrogenases deficiency, Disorder of Sex Development, 46,XY diagnosis, Gynecomastia diagnosis, Steroid Metabolism, Inborn Errors diagnosis
- Abstract
Steroid 17β-hydroxysteroid dehydrogenase III (17β-HSD3) deficiency is a rare autosomal recessive disorder that usually presents in patients with a 46,XY karyotype with ambiguous genitalia at birth. The 17β-HSD3 enzyme, which is encoded by the HSD17B3 gene, converts gonadal delta-4 androstenedione (Δ4) to testosterone (T). Such 17β-HSD3 enzyme deficiency is expected to lead to an increased ratio of D4 to T when the patient undergoes a human chorionic gonadotropin stimulation (hCG) test. Two patients with 46,XY disorders of sexual differentiation were studied. Serum D4 and T levels were measured by HPLC tandem mass spectrometry. As one of the patients was born to consanguineous parents, we performed single nucleotide polymorphism (SNP) microarray to analyze regions of homozygosity (ROH). The HSD17B3 gene was sequenced using the Sanger method. Contrary to expectations, both patients demonstrated decreased D4/T ratio after hCG stimulation. Initial sequencing results for the androgen receptor or 5α-reductase were negative for mutations. ROH analysis identified HSD17B3 as a candidate gene that might cause the disease. Sanger sequencing of the HSD17B3 gene confirmed 17β-HSD3 deficiency in both patients. Serum D4/T ratios are not reliable parameters for the diagnosis of 17β-HSD3 deficiency. Molecular genetic analysis provides accurate diagnosis.
- Published
- 2015
- Full Text
- View/download PDF
28. The clinical, structural, and biological features of neovaginas: a comparison of the Frank and the McIndoe techniques.
- Author
-
Hayashida SA, Soares JM Jr, Costa EM, da Fonseca AM, Maciel GA, Mendonça BB, and Baracat EC
- Subjects
- 46, XX Disorders of Sex Development surgery, Adolescent, Adult, Color, Congenital Abnormalities surgery, Dyspareunia etiology, Estrogens analysis, Female, Gynecologic Surgical Procedures adverse effects, Humans, Hydrogen-Ion Concentration, Mucous Membrane pathology, Mucous Membrane physiopathology, Mullerian Ducts abnormalities, Mullerian Ducts surgery, Retrospective Studies, Sexuality, Skin Transplantation, Vagina abnormalities, Vagina microbiology, Young Adult, Gynecologic Surgical Procedures methods, Mucous Membrane surgery, Surgically-Created Structures microbiology, Surgically-Created Structures physiology, Vagina anatomy & histology, Vagina surgery
- Abstract
Objective: To compare two methods of neovagina construction, the Frank and McIndoe techniques, in terms of structural and biological aspects., Study Design: A total of 55 subjects were included in this retrospective study: 43 underwent the Frank technique (FT) and 12 underwent the McIndoe technique (MT). A clinical evaluation and a comparison of the structural (color, shine, presence of hair, and histology) and biological (bacteriological, pH, and hormonal determinations) features were performed. Statistical analysis was performed using the Fisher and Mann-Whitney tests., Results: The time to achieve a functional neovagina using the FT was longer than when using the MT (9.8±5.3 versus 5.8±2.9 months) (p=0.01). The neovaginal wall of the MT skin grafts was more rigid and drier, and it did not exhibit a shine in the way that the FT skin grafts did. The lining of the cavity formed by the FT in all subjects was similar to that of vaginal mucosa, whereas the lining formed by the MT persisted as a skin graft in 83.3% of the cases. The pH was lower for the FT (p<0.01), and Döderlein bacilli were present in 90% of the FT neovaginas but absent from the MT neovaginas. In the latter, flora with anaerobic bacteria was present. Hormonal cytology showed estrogen activity in 100% of the FT neovaginas, but there was no such activity in the MT neovaginas., Conclusions: Our data suggest that the FT may be clinically, structurally, and biologically superior to the MT for the creation of neovaginas and is also less costly., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
29. Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay.
- Author
-
Beneduzzi D, Trarbach EB, Min L, Jorge AA, Garmes HM, Renk AC, Fichna M, Fichna P, Arantes KA, Costa EM, Zhang A, Adeola O, Wen J, Carroll RS, Mendonça BB, Kaiser UB, Latronico AC, and Silveira LF
- Subjects
- Adolescent, Animals, COS Cells, Chlorocebus aethiops, DNA Mutational Analysis, Female, Gene Frequency, Genetic Association Studies, Growth Disorders complications, Humans, Male, Polymorphism, Single Nucleotide, Puberty, Delayed complications, Growth Disorders genetics, Mutation, Puberty, Delayed genetics, Receptors, LHRH genetics
- Abstract
Objective: To analyze the GNRHR in patients with normosmic isolated hypogonadotropic hypogonadism (IHH) and constitutional delay of growth and puberty (CDGP)., Design: Molecular analysis and in vitro experiments correlated with phenotype., Setting: Academic medical center., Patient(s): A total of 110 individuals with normosmic IHH (74 male patients) and 50 with CDGP., Intervention(s): GNRHR coding region was amplified and sequenced., Main Outcome Measure(s): Novel variants were submitted to in vitro analysis. Frequency of mutations and genotype-phenotype correlation were analyzed. Microsatellite markers flanking GNRHR were examined in patients carrying the same mutation to investigate a possible founder effect., Result(s): Eleven IHH patients (10%) carried biallelic GNRHR mutations. In vitro analysis of novel variants (p.Y283H and p.V134G) demonstrated complete inactivation. The founder effect study revealed that Brazilian patients carrying the p.R139H mutation shared the same haplotype. Phenotypic spectrum in patients with GNRHR mutations varied from complete GnRH deficiency to partial and reversible IHH, with a relatively good genotype-phenotype correlation. One boy with CDGP was heterozygous for the p.Q106R variant, which was not considered to be pathogenic., Conclusion(s): GNRHR mutations are a frequent cause of congenital normosmic IHH and should be the first candidate gene for genetic screening in this condition, especially in autosomal recessive familial cases. The founder effect study suggested that the p.R139H mutation arises from a common ancestor in the Brazilian population. Finally, mutations in GNRHR do not appear to be involved in the pathogenesis of CDGP., (Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
30. [Analysis of an iodide radioimmunoassay for 11-deoxicortisol measurement].
- Author
-
Madeira JL, Bussmann LZ, Lima-Valassi HP, and Mendonça BB
- Subjects
- 17-alpha-Hydroxyprogesterone analysis, Bias, Biomarkers blood, Chromatography, High Pressure Liquid, Humans, Radioimmunoassay methods, Reference Standards, Reproducibility of Results, Sensitivity and Specificity, Tandem Mass Spectrometry, Adrenal Hyperplasia, Congenital diagnosis, Cortodoxone blood, Iodine Radioisotopes, Reagent Kits, Diagnostic standards
- Abstract
Objective: Our aim was to correlate 11-deoxycortisol levels obtained by two currently available techniques for 11-deoxycortisol measurement: radioimmunoassay, and high performance liquid chromatography followed by tandem mass spectrometry (MS/MS). The latter is the gold standard method for steroid hormone measurement., Materials and Methods: We selected 88 samples and the results of these two methods were compared by Deming regression., Results: The analytical sensitivity of the RIA was 0.30 ng/mL, with inadequate linearity and inadequate precision profile (34% of the samples had a CV ≥ 20%). From the selected samples, 54 had measurable levels of 11-deoxycortisol in both methods and were used in the comparison. The comparison of RIA with LC-MS/MS showed an overestimation of the results by RIA. The correlation coefficient was 0.610; linear regression slope was 3.751; and the intercept was 0.145, indicating a poor correlation between the two methods., Conclusion: We concluded that 11-deoxycortisol measured by radioimmunoassay, despite a good analytical sensitivity, showed very low specificity, precluding its use as a reliable method for 11-deoxycortisol measurement.
- Published
- 2014
- Full Text
- View/download PDF
31. Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.
- Author
-
Maciel GA, Moreira RP, Bugano DD, Hayashida SA, Marcondes JA, Gomes LG, Mendonça BB, Bachega TA, and Baracat EC
- Subjects
- Adult, Alleles, Body Mass Index, Cholesterol, Female, Fluoroimmunoassay, Gene Frequency, Genes, bcl-1 genetics, Humans, Hypertension genetics, Hypertension metabolism, Insulin Resistance genetics, Metabolic Syndrome genetics, Metabolic Syndrome metabolism, Obesity genetics, Obesity metabolism, Polymerase Chain Reaction, Risk Factors, Statistics, Nonparametric, Time Factors, Young Adult, Polycystic Ovary Syndrome genetics, Polycystic Ovary Syndrome metabolism, Polymorphism, Genetic genetics, Receptors, Glucocorticoid genetics
- Abstract
Objectives: We aimed to investigate whether glucocorticoid receptor gene polymorphisms are associated with clinical and metabolic profiles in patients with polycystic ovary syndrome. Polycystic ovary syndrome is a complex endocrine disease that affects 5-8% of women and may be associated with metabolic syndrome, which is a risk factor for cardiovascular disease. Cortisol action and dysregulation account for metabolic syndrome development in the general population. As glucocorticoid receptor gene (NR3C1) polymorphisms regulate cortisol sensitivity, we hypothesized that variants of this gene may be involved in the adverse metabolic profiles of patients with polycystic ovary syndrome., Method: Clinical, metabolic and hormonal profiles were evaluated in 97 patients with polycystic ovary syndrome who were diagnosed according to the Rotterdam criteria. The alleles of the glucocorticoid gene were genotyped. Association analyses were performed using the appropriate statistical tests., Results: Obesity and metabolic syndrome were observed in 42.3% and 26.8% of patients, respectively. Body mass index was positively correlated with blood pressure, triglyceride, LDL-c, total cholesterol, glucose and insulin levels as well as HOMA-IR values and inversely correlated with HDL-c and SHBG levels. The BclI and A3669G variants were found in 24.7% and 13.4% of alleles, respectively. BclI carriers presented a lower frequency of insulin resistance compared with wild-type subjects., Conclusion: The BclI variant is associated with a lower frequency of insulin resistance in women with polycystic ovary syndrome. Glucocorticoid gene polymorphism screening during treatment of the syndrome may be useful for identifying subgroups of at-risk patients who would benefit the most from personalized treatment.
- Published
- 2014
- Full Text
- View/download PDF
32. Karyotypic conservatism in five species of Prochilodus (Characiformes, Prochilodontidae) disclosed by cytogenetic markers.
- Author
-
Voltolin TA, Penitente M, Mendonça BB, Senhorini JA, Foresti F, and Porto-Foresti F
- Abstract
The family Prochilodontidae is considered a group with well conserved chromosomes characterized by their number, morphology and banding patterns. Thence, our study aimed at accomplishing a cytogenetic analysis with conventional methods (Giemsa staining, silver staining of the nucleolus organizer regions-AgNOR, and C-banding) and fluorescence in situ hybridization (FISH) with 18S and 5S ribosomal DNA probes in five species of the Prochilodus genus (Prochilodus argenteus, Prochilodus brevis, Prochilodus costatus, Prochilodus lineatus and Prochilodus nigricans) collected from different Brazilian hydrographic basins. The results revealed conservatism in chromosome number, morphology, AgNORs 18S and 5S rDNAs location and constitutive heterochromatin distribution patterns. The minor differences observed in this work, such as an Ag-NOR on a P. argenteus chromosome and a distinct C-banding pattern in P. lineatus, are not sufficient to question the conservatism described for this group. Future work using repetitive DNA sequences as probes for FISH will be interesting to further test the cytogenetic conservatism in Prochilodus.
- Published
- 2013
- Full Text
- View/download PDF
33. Chromosomal location of retrotransposable REX 1 in the genomes in five Prochilodus (Teleostei: Characiformes.
- Author
-
Voltolin TA, Mendonça BB, Ferreira DC, Senhorini JA, Foresti F, and Porto-Foresti F
- Abstract
Transposable elements are repetitive DNA sequences comprising a group of segments able to move and carry sequences within the genome. Studies involving comparative genomics have revealed that most vertebrates have different populations of transposable elements with significant differences among species of the same lineage. Few studies have been conducted in fish, the most diverse group of vertebrates, with the objective to locate different types of transposable elements. Therefore, this study proposed to map the retrotransposable element Rex1 applying Fluorescent in situ Hybridization (FISH) in five species of the genus Prochilodus ( Prochilodus argenteus, Prochilodus brevis, Prochilodus costatus, Prochilodus lineatus and Prochilodus nigricans ). After the application of the Rex1 probe, scattered markings were found throughout the genome of analyzed species, and also the presence of small clusters located in the centromeric and telomeric regions coincident with the heterochromatin distribution pattern. This was the first description of the retrotransposable element Rex1 in Prochilodus genome seeking for a better understanding of the distribution pattern of these retrotransposons in the genome of teleost fish.
- Published
- 2013
- Full Text
- View/download PDF
34. Unrecognized diabetes and myocardial necrosis: predictors of hyperglycemia in myocardial infarction.
- Author
-
Ladeira RT, Baracioli LM, Faulin TE, Abdalla DS, Seydell TM, Maranhão RC, Mendonça BB, Strunz CC, Castro Id, and Nicolau JC
- Subjects
- Biomarkers blood, Blood Coagulation physiology, Creatine Kinase, MB Form blood, Diabetes Mellitus blood, Epidemiologic Methods, Female, Glycated Hemoglobin analysis, Humans, Hyperglycemia blood, Inflammation blood, Insulin blood, Lipoproteins blood, Male, Middle Aged, Myocardial Infarction pathology, Necrosis, Stress, Physiological physiology, Diabetes Mellitus diagnosis, Hyperglycemia diagnosis, Myocardial Infarction blood, Troponin blood
- Abstract
Background: Hyperglycemia in the acute phase of myocardial infarction is an important prognostic factor. However, its pathophysiology is not fully understood., Objective: To analyze simultaneously the correlation between hyperglycemia and biochemical markers related to stress, glucose and lipid metabolism, coagulation, inflammation, and myocardial necrosis. METHODS Eighty patients with acute myocardial infarction were prospectively included. The following parameters were analyzed: blood glucose; stress hormones (cortisol and norepinephrine); glucose metabolism factors [glycated hemoglobin (HbA1c); insulin]; lipoproteins (total cholesterol, LDL, HDL, minimally modified electronegative LDL, and adiponectin); glycerides (triglycerides, VLDL and fatty acids); coagulation factors (factor VII, fibrinogen, plasminogen activator inhibitor-1); inflammation (high-sensitivity C reactive protein); and myocardial necrosis (CK-MB and troponin). Continuous variables were converted into degrees of relevance using fuzzy logic., Results: Significant correlation was observed between hyperglycemia and glucose metabolism (p < 0.001), lipoproteins (p = 0.03), and necrosis factors (p = 0.03). In the multivariate analysis, only glucose metabolism (OR = 4.3; CI = 2.1-68.9; and p < 0.001) and myocardial necrosis (OR = 22.5; CI = 2-253; and p = 0.012) showed independent and significant correlation. For the analysis of the influence of history of diabetes mellitus, a regression model including only patients without diabetes mellitus was developed, and the results did not change. Finally, in the model adjusted for age, gender, and clinical variables (history of diabetes mellitus, hypertension and dyslipidemia), three variables maintained a significant and independent association with hyperglycemia: glucose metabolism (OR = 24.1; CI = 4.8-122.1; and p < 0.001), myocardial necrosis (OR = 21.9; CI = 1.3-360.9; and p = 0.03), and history of DM (OR = 27; CI = 3.7-195.7; and p = 0.001)., Conclusion: Glucose metabolism and myocardial necrosis markers were the best predictors of hyperglycemia in patients with acute myocardial infarction.
- Published
- 2013
35. Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders.
- Author
-
Tusset C, Noel SD, Trarbach EB, Silveira LF, Jorge AA, Brito VN, Cukier P, Seminara SB, Mendonça BB, Kaiser UB, and Latronico AC
- Subjects
- Adolescent, Adult, Case-Control Studies, Child, Child, Preschool, Cohort Studies, Female, Humans, Male, Polymorphism, Single Nucleotide genetics, Young Adult, Growth Disorders genetics, Hypogonadism genetics, Neurokinin B genetics, Puberty, Delayed genetics, Puberty, Precocious genetics, Receptors, Neurokinin-3 genetics
- Abstract
Objective: To investigate the presence of variants in the TAC3 and TACR3 genes, which encode NKB and its receptor (NK3R), respectively, in a large cohort of patients with idiopathic central pubertal disorders., Subjects and Methods: Two hundred and thirty seven patients were studied: 114 with central precocious puberty (CPP), 73 with normosmic isolated hypogonadotropic hypogonadism (IHH), and 50 with constitutional delay of growth and puberty (CDGP). The control group consisted of 150 Brazilian individuals with normal pubertal development. Genomic DNA was extracted from peripheral blood and the entire coding region of both TAC3 and TACR3 genes were amplified and automatically sequenced., Results: We identified one variant (p.A63P) in NKB and four variants, p.G18D, p.L58L (c.172C>T), p.W275* and p.A449S in NK3R, which were absent in the control group. The p.A63P variant was identified in a girl with CPP, and p.A449S in a girl with CDGP. The known p.G18D, p.L58L, and p.W275* variants were identified in three unrelated males with normosmic IHH., Conclusion: Rare variants in the TAC3 and TACR3 genes were identified in patients with central pubertal disorders. Loss-of-function variants of TACR3 were associated with the normosmic IHH phenotype.
- Published
- 2012
- Full Text
- View/download PDF
36. Mutational analysis of the necdin gene in patients with congenital isolated hypogonadotropic hypogonadism.
- Author
-
Beneduzzi D, Iyer AK, Trarbach EB, Silveira-Neto AP, Silveira LG, Tusset C, Yip K, Mendonça BB, Mellon PL, and Latronico AC
- Subjects
- Animals, Base Sequence, Brazil, DNA Mutational Analysis, Female, Humans, Hypogonadism congenital, Kallmann Syndrome genetics, Male, Mice, Nerve Tissue Proteins, Nuclear Proteins, Pedigree, Receptor, Fibroblast Growth Factor, Type 1 genetics, Hypogonadism genetics, Prader-Willi Syndrome genetics
- Abstract
Context: Necdin activates GNRH gene expression and is fundamental for the development, migration, and axonal extension of murine GNRH neurons. In humans, necdin plays a potential role in the hypogonadotropic hypogonadism phenotype in patients with Prader-Willi syndrome., Aim: To investigate necdin gene (NDN) variants in patients with isolated hypogonadotropic hypogonadism (IHH)., Patients and Methods: We studied 160 Brazilian patients with IHH, which includes 92 with Kallmann syndrome and 68 with normosmic IHH. Genomic DNA was extracted and the single NDN exon was amplified and sequenced. To measure GNRH transcriptional activity, luciferase reporter plasmids containing GNRH regulatory regions were transiently transfected into GT1-7 cells in the presence and absence of overexpressed wild-type or mutant necdin., Results: A heterozygous variant of necdin, p.V318A, was identified in a 23-year-old male with Kallmann syndrome. The p.V318A was also present in affected aunt and his father and was absent in 100 Brazilian control subjects. Previous FGFR1 gene analysis revealed a missense mutation (p.P366L) in this family. Functional studies revealed a minor difference in the activation of GNRH transcription by mutant protein compared with wild type in that a significant impairment of the necdin protein activity threshold was observed., Conclusion: A rare variant of necdin (p.V318A) was described in a family with Kallmann syndrome associated with a FGFR1 mutation. Familial segregation and in vitro analysis suggested that this non-synonymous variant did not have a direct causative role in the hypogonadism phenotype. NDN mutations are not a frequent cause of congenital IHH.
- Published
- 2011
- Full Text
- View/download PDF
37. PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.
- Author
-
Cani CM, Matushita H, Carvalho LR, Soares IC, Brito LP, Almeida MQ, and Mendonça BB
- Subjects
- Adolescent, Child, Child, Preschool, Craniopharyngioma pathology, DNA Mutational Analysis, Female, Gene Expression, Humans, Infant, Male, Pituitary Neoplasms pathology, Signal Transduction genetics, Transcriptional Activation genetics, Wnt Proteins genetics, Young Adult, Craniopharyngioma genetics, Homeodomain Proteins genetics, Pituitary Neoplasms genetics, beta Catenin genetics
- Abstract
Introduction: Activating mutations in exon 3 of the β-catenin gene are involved in the pathogenesis of adamantinomatous craniopharyngiomas. Recently, the interaction between β-catenin and PROP1 has been shown to be responsible for pituitary cell lineage determination. We hypothesized that dysregulated PROP1 expression could also be involved in the pathogenesis of craniopharyngiomas, Objectives: To determine whether dysregulated gene expression was responsible for tumor pathogenesis in adamantinomatous craniopharyngiomas, the β-catenin gene was screened for mutations, and the expression of the β-catenin gene and PROP1 was evaluated. β-catenin gene was amplified and sequenced from 14 samples of adamantinomatous craniopharyngiomas. PROP1 and β-catenin gene expression was assessed by real-time RT-PCR from 12 samples, and β-catenin immunohistochemistry was performed on 11 samples., Results: Mutations in the β-catenin gene were identified in 64% of the adamantinomatous craniopharyngiomas samples. Evidence of β-catenin gene overexpression was found in 71% of the tumors with β-catenin mutations and in 40% of the tumors without mutations, and β-catenin immunohistochemistry revealed a nuclear staining pattern for each of the analyzed samples. PROP1 expression was undetectable in all of the tumor samples., Conclusion: We found evidence of β-catenin gene overexpression in the majority of adamantinomatous craniopharyngiomas, and we also detected a nuclear β-catenin staining pattern regardless of the presence of a β-catenin gene mutation. These results suggest that WNT signaling activation plays an important role in the pathogenesis of adamantinomatous craniopharyngiomas. Additionally, this study was the first to evaluate PROP1 expression in adamantinomatous craniopharyngiomas, and the absence of PROP1 expression indicates that this gene is not involved in the pathogenesis of this tumor, at least in this cohort.
- Published
- 2011
- Full Text
- View/download PDF
38. Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells.
- Author
-
Lovisolo SM, Mendonça BB, Pinto EM, Manna TD, Saldiva PH, and Zerbini MC
- Subjects
- Brazil, Cell Proliferation, Congenital Hyperinsulinism surgery, Humans, Immunohistochemistry, Infant, Newborn, Pancreatectomy, Sulfonylurea Receptors, ATP-Binding Cassette Transporters genetics, Congenital Hyperinsulinism genetics, Congenital Hyperinsulinism pathology, Insulin-Secreting Cells pathology, Potassium Channels, Inwardly Rectifying genetics, Receptors, Drug genetics
- Abstract
Congenital hyperinsulinism (CHI) is a rare pancreatic β-cell disease of neonates, characterized by inappropriate insulin secretion with severe persistent hypoglycemia, with regard to which many questions remain to be answered, despite the important acquisition of its molecular mechanisms in the last decade. The aim of this study was to examine pancreatic histology, β-cell proliferation (immunohistochemistry with double staining for Ki-67/insulin), and β-cell adenosine triphosphate-sensitive potassium channels genes from 11 Brazilian patients with severe medically unresponsive CHI who underwent pancreatectomy. Pancreatic histology and β-cell proliferation in CHI patients were compared to pancreatic samples from 19 age-matched controls. Ten cases were classified as diffuse form (D-CHI) and 1 as focal form (F-CHI). β-cell nucleomegaly and abundant cytoplasm were absent in controls and were observed only in D-CHI patients. The Ki-67 labeling index (Ki-67-LI) was used to differentiate the adenomatous areas of the F-CHI case (10.15%) from the "loose cluster of islets" found in 2 D-CHI samples (2.29% and 2.43%) and 1 control (1.54%) sample. The Ki-67-LI was higher in the F-CHI adenomatous areas, but D-CHI patients also had significantly greater Ki-67-LI (mean value = 2.41%) than age-matched controls (mean value = 1.87%) (P = 0.009). In this 1st genetic study of CHI patients in Brazil, no mutations or new polymorphisms were found in the 33-37 exons of the ABCC8 gene (SUR1) or in the entire exon of the KCNJ11 gene (Kir 6.2) in 4 of 4 patients evaluated. On the other hand, enhanced β-cell proliferation seems to be a constant feature in CHI patients, both in diffuse and focal forms.
- Published
- 2010
- Full Text
- View/download PDF
39. Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.
- Author
-
Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, Lyons RH, Brinkmeier ML, Raetzman LT, Carninci P, Mortensen AH, Hayashizaki Y, Arnhold IJ, Mendonça BB, Brue T, and Camper SA
- Subjects
- Animals, Cell Communication genetics, Cell Communication physiology, Female, Homeodomain Proteins genetics, Homeodomain Proteins physiology, Human Growth Hormone deficiency, Human Growth Hormone physiology, Humans, Male, Mice, Transcription Factors genetics, Transcription Factors physiology, Gene Expression Regulation, Developmental, Genes, Developmental, Organogenesis genetics, Pituitary Gland growth & development
- Abstract
Defects in pituitary gland organogenesis are sometimes associated with congenital anomalies that affect head development. Lesions in transcription factors and signaling pathways explain some of these developmental syndromes. Basic research studies, including the characterization of genetically engineered mice, provide a mechanistic framework for understanding how mutations create the clinical characteristics observed in patients. Defects in BMP, WNT, Notch, and FGF signaling pathways affect induction and growth of the pituitary primordium and other organ systems partly by altering the balance between signaling pathways. The PITX and LHX transcription factor families influence pituitary and head development and are clinically relevant. A few later-acting transcription factors have pituitary-specific effects, including PROP1, POU1F1 (PIT1), and TPIT (TBX19), while others, such as NeuroD1 and NR5A1 (SF1), are syndromic, influencing development of other endocrine organs. We conducted a survey of genes transcribed in developing mouse pituitary to find candidates for cases of pituitary hormone deficiency of unknown etiology. We identified numerous transcription factors that are members of gene families with roles in syndromic or non-syndromic pituitary hormone deficiency. This collection is a rich source for future basic and clinical studies.
- Published
- 2010
- Full Text
- View/download PDF
40. A novel homozygous splice acceptor site mutation of KISS1R in two siblings with normosmic isolated hypogonadotropic hypogonadism.
- Author
-
Teles MG, Trarbach EB, Noel SD, Guerra-Junior G, Jorge A, Beneduzzi D, Bianco SD, Mukherjee A, Baptista MT, Costa EM, De Castro M, Mendonça BB, Kaiser UB, and Latronico AC
- Subjects
- Animals, Brazil, COS Cells, Chlorocebus aethiops, Female, Humans, Male, Mutation genetics, Puberty, Delayed genetics, Receptors, Kisspeptin-1, Siblings, Homozygote, Hypogonadism genetics, RNA Splice Sites genetics, Receptors, G-Protein-Coupled genetics
- Abstract
Context: Loss-of-function mutations of the kisspeptin-1 receptor gene, KISS1R, have been identified in patients with normosmic isolated hypogonadotropic hypogonadism (nIHH)., Objective: To investigate KISS1R defects in patients with absent or delayed puberty., Patients: We investigated KISS1R gene defects in a cohort of 99 Brazilian patients with nIHH or constitutional delay of puberty (CDP)., Methods: The entire coding region of KISS1R was amplified by PCR followed by automatic sequencing. In addition, screening for KISS1R exonic deletions was performed by multiplex ligation-dependent probe amplification., Results: One novel homozygous KISS1R mutation was identified in two siblings with nIHH. This variant was an insertion/deletion (indel) mutation characterized by the deletion of three nucleotides (GCA) at position -2 to -4, and by the insertion of seven nucleotides (ACCGGCT) at the same position, within the 3' splice acceptor site of intron 2 of KISS1R. The brothers who carried this KISS1R mutation had no clinical evidence of pubertal development at the ages of 14 and 20 years. Computational analysis of this indel mutation predicted the generation of an abnormal protein. In addition, a new heterozygous KISS1R variant (p.E252Q) was identified in a male patient with sporadic nIHH. However, in vitro studies of this variant did not demonstrate functional impairment. Only known polymorphisms were identified in patients with CDP., Conclusion: Loss-of-function mutations of KISS1R represents a rare cause of nIHH, and was absent in patients with CDP. We have described a novel KISS1R homozygous splice acceptor site mutation in the familial form of nIHH.
- Published
- 2010
- Full Text
- View/download PDF
41. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.
- Author
-
Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendonça BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, and Seminara SB
- Subjects
- Adolescent, Adult, Amino Acid Sequence, Animals, COS Cells, Chlorocebus aethiops, Codon, Nonsense genetics, DNA Mutational Analysis, Ethnicity, Female, Fertility genetics, Genetic Variation, Humans, Infant, Newborn, Male, Molecular Sequence Data, Mutation physiology, Pedigree, Puberty physiology, Sex Characteristics, Transfection, Young Adult, Gonadotropin-Releasing Hormone metabolism, Neurokinin B genetics, Neurokinin B pharmacology, Receptors, Neurokinin-3 genetics, Receptors, Tachykinin genetics, Tachykinins genetics
- Abstract
Context: Mutations in TAC3 and TACR3 (encoding neurokinin B and its receptor) have been identified in Turkish patients with idiopathic hypogonadotropic hypogonadism (IHH), but broader populations have not yet been tested and genotype-phenotype correlations have not been established., Objective: A broad cohort of normosmic IHH probands was screened for mutations in TAC3/TACR3 to evaluate the prevalence of such mutations and define the genotype/phenotype relationships., Design and Setting: The study consisted of sequencing of TAC3/TACR3, in vitro functional assays, and neuroendocrine phenotyping conducted in tertiary care centers worldwide., Patients or Other Participants: 345 probands, 18 family members, and 292 controls were studied., Intervention: Reproductive phenotypes throughout reproductive life and before and after therapy were examined., Main Outcome Measure: Rare sequence variants in TAC3/TACR3 were detected., Results: In TACR3, 19 probands harbored 13 distinct coding sequence rare nucleotide variants [three nonsense mutations, six nonsynonymous, four synonymous (one predicted to affect splicing)]. In TAC3, one homozygous single base pair deletion was identified, resulting in complete loss of the neurokinin B decapeptide. Phenotypic information was available on 16 males and seven females with coding sequence variants in TACR3/TAC3. Of the 16 males, 15 had microphallus; none of the females had spontaneous thelarche. Seven of the 16 males and five of the seven females were assessed after discontinuation of therapy; six of the seven males and four of the five females demonstrated evidence for reversibility of their hypogonadotropism., Conclusions: Mutations in the neurokinin B pathway are relatively common as causes of hypogonadism. Although the neurokinin B pathway appears essential during early sexual development, its importance in sustaining the integrity of the hypothalamic-pituitary-gonadal axis appears attenuated over time.
- Published
- 2010
- Full Text
- View/download PDF
42. Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients.
- Author
-
Soardi FC, Penachioni JY, Justo GZ, Bachega TA, Inácio M, Mendonça BB, de Castro M, and de Mello MP
- Subjects
- Adult, Amino Acid Sequence, Animals, Base Sequence, COS Cells, Child, Chlorocebus aethiops, Female, Humans, Molecular Sequence Data, Polymorphism, Single Nucleotide, Adrenal Hyperplasia, Congenital genetics, Mutation, Steroid 11-beta-Hydroxylase genetics
- Abstract
Background: Deficiency of 11 beta-hydroxylase results in the impairment of the last step of cortisol synthesis. In females, the phenotype of this disorder includes different degrees of genital ambiguity and arterial hypertension. Mutations in the CYP11B1 gene are responsible for this disease., Objective: The objective of the study was to screen the CYP11B1 gene for mutations in two unrelated Brazilian females with congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency., Design: The coding and intron-exon junction regions of CYP11B1 were totally sequenced. A putative splice mutation was further investigated by minigene transcription., Results: We report two novel CYP11B1 mutations in these Brazilian patients. An Arabian Lebanese descendent female was found to be homozygous for a cytosine insertion at the beginning of exon 8, changing the 404 arginine to proline. It alters the open reading frame, creating a putative truncated protein at 421 residue, which eliminates the domain necessary for the association of heme prosthetic group. A severely virilized female was homozygous for the g.2791G>A transition in the last position of exon 4. This nucleotide is also part of 5' intron 4 donor splice site consensus sequence. Minigene experiments demonstrated that g.2791G>A activated an alternative splice site within exon 4, leading to a 45-bp deletion in the transcript. The putative translation of such modified mRNA indicates a truncated protein at residue 280., Conclusions: We describe two novel mutations, g.4671_4672insC and g.2791G>A, that drastically affects normal protein structure. These mutations abolish normal enzyme activity, leading to a severe phenotype of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
- Published
- 2009
- Full Text
- View/download PDF
43. [Prostate Development in girls with congenital adrenal hyperplasia: effect of androgens intra-uterus or inappropriate postnatal hormonal control? ].
- Author
-
Gomes LG, Mendonça BB, and Bachega TA
- Subjects
- Female, Humans, Male, Prostate growth & development, Adrenal Hyperplasia, Congenital complications, Androgens metabolism, Prostate embryology, Virilism etiology
- Published
- 2009
- Full Text
- View/download PDF
44. Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency.
- Author
-
Gomes LG, Huang N, Agrawal V, Mendonça BB, Bachega TA, and Miller WL
- Subjects
- 17-alpha-Hydroxyprogesterone metabolism, Aryl Hydrocarbon Hydroxylases genetics, Child, Child, Preschool, Cytochrome P-450 CYP2C19, Female, Humans, Hydroxylation, Male, Progesterone metabolism, Adrenal Hyperplasia, Congenital enzymology, Aryl Hydrocarbon Hydroxylases physiology, Cytochrome P-450 CYP3A physiology
- Abstract
Context: 21-Hydroxylase deficiency (21OHD) is caused by CYP21A2 gene mutations disrupting the adrenal 21-hydroxylase, P450c21. CYP21A2 mutations generally correlate well with the 21OHD phenotype, but some children with severe CYP21A2 mutations have residual 21-hydroxylase activity. Some hepatic P450 enzymes can 21-hydroxylate progesterone, but their physiological relevance in modifying 21OHD is not known., Objective: We determined the ability of CYP2C19 and CYP3A4 to 21-hydroxylate progesterone and 17-hydroxyprogesterone (17OHP), determined the impact of the common P450 oxidoreductase (POR) variant A503V on these activities, and examined correlations between CYP2C19 variants and phenotype in patients with 21OHD., Methods: Bacterially expressed, N-terminally modified, C-His-tagged human P450c21, CYP2C19, and CYP3A4 were combined with bacterially expressed wild-type and A503V POR. The 21-hydroxylation of radiolabeled progesterone and 17OHP was assessed, and the Michaelis constant (Km) and maximum velocity (Vmax) of the reactions were measured. CYP2C19 was genotyped in 21OHD patients with genotypes predicting severe congenital adrenal hyperplasia., Results: Compared to P450c21, the Vmax/Km for 21-hydroxylation of progesterone by CYP2C19 and CYP3A4 were 17 and 10%, respectively. With both forms of POR, the Km for P450c21 was approximately 2.6 microm, the Km for CYP2C19 was approximately 11 microm, and the Km for CYP3A4 was approximately 110 microm. Neither CYP2C19 nor CYP3A4 could 21-hydroxylate 17OHP. The CYP2C19 ultrametabolizer allele CYP2C19 17 was homozygous in one of five patients with a 21OHD phenotype that was milder than predicted by the CYP21A2 genotype., Conclusions: CYP2C19 and CYP3A4 can 21-hydroxylate progesterone but not 17OHP, possibly ameliorating mineralocorticoid deficiency, but not glucocorticoid deficiency. Multiple enzymes probably contribute to extraadrenal 21-hydroxylation.
- Published
- 2009
- Full Text
- View/download PDF
45. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
- Author
-
Romanholi DJ, Machado MC, Pereira CC, Danilovic DS, Pereira MA, Cescato VA, Cunha Neto MB, Musolino NR, de Mendonça BB, and Salgado LR
- Subjects
- Adolescent, Adult, Aged, Antidiuretic Agents administration & dosage, Antidiuretic Agents pharmacology, Child, Deamino Arginine Vasopressin administration & dosage, Diagnostic Techniques, Endocrine, Female, Humans, Hydrocortisone metabolism, Male, Middle Aged, Pituitary ACTH Hypersecretion blood, Pituitary ACTH Hypersecretion pathology, Postoperative Complications blood, Postoperative Period, Prognosis, Recurrence, Retrospective Studies, Risk Factors, Young Adult, Deamino Arginine Vasopressin pharmacology, Hydrocortisone blood, Pituitary ACTH Hypersecretion diagnosis, Pituitary ACTH Hypersecretion surgery, Postoperative Complications diagnosis
- Abstract
Unlabelled: In the early postoperative period of Cushing's disease patients, desmopressin may stimulate ACTH secretion in the remnant corticotrophic tumour, but not in nontumour suppressed cells., Objective: The aim of this study is to evaluate the serum cortisol responses to desmopressin after pituitary surgery, establishing an optimal cut-off for absolute increment (Delta) of serum cortisol (F) suitable to predict recurrence risk., Design: Retrospective case record study., Patients: Fifty-seven Cushing's disease patients submitted to pituitary surgery and desmopressin stimulation in the early postoperative with a long-term follow-up (20-161 months) were studied., Methods and Measurements: Serum cortisol levels after desmopressin test (10 microg i.v.) 15-30 days after adenomectomy were used to determine DeltaF (absolute increment of F: F peak - F baseline). Sensitivity and specificity of DeltaF were calculated and a ROC curve was performed to establish an optimal cut-off for DeltaF to predict recurrence risk., Results: Fifteen patients had immediate postoperative failure (basal F > 165 nmol/l; 6 microg/dl) and one patient was lost during the follow-up. Forty-one patients achieved initial remission and were followed-up. Five of 11 patients who recurred had DeltaF > 193 nmol/l (7 microg/dl), but none of 30 patients who remained in prolonged remission showed DeltaF > 193 nmol/l after postoperative desmopressin stimulation., Conclusions: Persistence of cortisol response (DeltaF > 193 nmol/l) to desmopressin in the early postoperative period can help to identify Cushing's disease patients with initial remission who present risk for later recurrence.
- Published
- 2008
- Full Text
- View/download PDF
46. The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.
- Author
-
Gomes LG, Huang N, Agrawal V, Mendonça BB, Bachega TA, and Miller WL
- Subjects
- Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, NADPH-Ferrihemoprotein Reductase metabolism, Adrenal Hyperplasia, Congenital genetics, Mutation, NADPH-Ferrihemoprotein Reductase genetics
- Abstract
Context: 21-hydroxylase deficiency (21OHD) is a common genetic disorder caused by mutations in the CYP21A2 gene, which encodes the adrenal 21-hydroxylase, microsomal P450c21. CYP21A2 gene mutations generally correlate well with impaired P450c21 enzymatic activity and the clinical findings in 21OHD, but occasional discrepancies between genotype and phenotype suggest the effects of modifier genes. Mutations in P450 oxidoreductase (POR), the protein that transfers electrons from reduced nicotinamide adenine dinucleotide phosphate to all microsomal P450s, can ameliorate the 21OHD phenotype and, therefore, could be a modifier gene., Objectives: We sought to identify POR variants in patients with 21OHD having discordant phenotype and genotype, and to evaluate their effect on 21-hydroxylase activity., Patients and Methods: We determined the CYP21A2 genotypes of 313 Brazilian patients with 21OHD and correlated the genotype and phenotype. The POR gene was sequenced in 17 patients with discordant genotype and phenotype. Wild-type and A503V POR, and P450c21 were expressed in bacteria and reconstituted in vitro. Activities were assayed by conversion of [(14)C]progesterone to deoxycorticosterone and [(3)H]17-hydroxyprogesterone to 11-deoxycortisol, and assessed by thin layer chromatography and phosphorimaging., Results: The A503V POR variant was found in 10 of 30 alleles, the same ratio as in the normal population. There were no significant differences in Michaelis constant, maximum velocity and maximum velocity/Michaelis constant of 21-hydroxylase activity supported by wild-type and A503V POR., Conclusion: The only POR missense polymorphism found in atypical 21OHD patients was A503V. Although A503V reduces P450c17 enzymatic activity, it does not influence P450c21 activity, indicating that POR A503V does not modify the 21OHD phenotype.
- Published
- 2008
- Full Text
- View/download PDF
47. [Mathematical models for predicting growth responses to growth hormone replacement therapy].
- Author
-
Costalonga EF, Jorge AA, Mendonça BB, and Arnhold IJ
- Subjects
- Algorithms, Human Growth Hormone deficiency, Humans, Models, Statistical, Predictive Value of Tests, Regression Analysis, Body Height, Growth Disorders drug therapy, Hormone Replacement Therapy, Human Growth Hormone therapeutic use, Models, Biological
- Abstract
Growth prediction models are algorithms derived from multiple regression analyses including variables that influence growth responses to GH therapy in a defined group of subjects over a defined period of time. Mathematical equations can be derived from the knowledge acquired with the relative importance of each variable, which provide objective measurements of each subject's growth potential in response to GH therapy on different situations. Therefore, these equations can be used as tools to improve evidence-based decision regarding to growth promoting treatment strategies to be used in each child, optimizing cost-effectiveness with the lowest cumulative GH dose. Several models have already been developed to predict growth responses to GH for different short stature causes, but they still have low clinical usefulness, due to their low predictive power and low prevision accuracy. This has lead to a growing interest in the addition of new variables, such as biochemical or genetic markers, which could improve prevision accuracy and then allow, in the future, GH therapy individualization according to the specific needs of each child.
- Published
- 2008
- Full Text
- View/download PDF
48. [Noonan syndrome: from phenotype to growth hormone therapy].
- Author
-
Malaquias AC, Ferreira LV, Souza SC, Arnhold IJ, Mendonça BB, and Jorge AA
- Subjects
- Body Height genetics, Diagnosis, Differential, Failure to Thrive diagnosis, Failure to Thrive drug therapy, Human Growth Hormone therapeutic use, Humans, Mitogen-Activated Protein Kinases genetics, Noonan Syndrome diagnosis, Noonan Syndrome drug therapy, Phenotype, Protein Tyrosine Phosphatase, Non-Receptor Type 11 genetics, Pulmonary Valve Stenosis diagnosis, Failure to Thrive genetics, Human Growth Hormone deficiency, Noonan Syndrome genetics
- Abstract
Noonan Syndrome (NS) is one of the most common genetic syndromes and it is an important differential diagnosis in children with short stature, delayed puberty and cryptorchidism. NS is characterized by dysmorphic facial features, congenital heart defects and short stature, but there is a great variability in phenotype. NS may occur in a pattern consistent with autosomal dominant inheritance with almost complete penetrance. The diagnosis is based on a clinical score system proposed by van der Burgt e cols. in 1994. In recent years, germline mutations in the components of RAS-MAPK (mitogen activated protein kinase) pathway have been shown to be involved in the pathogenesis of NS. Mutations in PTPN11, KRAS, SOS1, RAF1 and MEK1 can explain 60-70% of NS molecular cause. Growth hormone therapy is proposed to correct the short stature observed in these patients. Recent studies suggest that the presence of PTPN11 mutations in patients with NS indicates a reduced growth response to short-term hrGH treatment. In this article, it is reviewed clinical and molecular aspects of NS and hrGH treatment for short stature.
- Published
- 2008
- Full Text
- View/download PDF
49. [Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].
- Author
-
Jorge AA, Nishi MY, Funari MF, Souza SC, Arnhold IJ, and Mendonça BB
- Subjects
- Dwarfism diagnosis, Dwarfism drug therapy, Genes, Homeobox genetics, Human Growth Hormone therapeutic use, Humans, Phenotype, Short Stature Homeobox Protein, Body Height genetics, Dwarfism genetics, Homeodomain Proteins genetics
- Abstract
Studies involving patients with short stature and partial deletion of sex chromosomes identified SHOX gene in the pseudoautosomal region of the X and Y chromosomes. SHOX haploinsufficiency is an important cause of short stature in a diversity of clinical conditions. It explains 2/3 of short stature observed in Turner syndrome (TS) patients. Heterozygous mutations in SHOX are observed in 77% of patients with Leri-Weill dyschondrosteosis, a common dominant inherited skeletal dysplasia and in 3% of children with idiopathic short stature, indicating that SHOX defects are the most frequent monogenetic cause of short stature. The sitting height/height ratio (SH/H) standard deviation score is a simple way to assess body proportions and together with a careful exam of other family members, effectively selected a group of patients that presented a high frequency of SHOX mutations. Growth hormone treatment of short stature due to TS is well established and considering the common etiology of short stature in patients with isolated defects of SHOX gene, this treatment is also proposed for these patients. Here, we review clinical, molecular and therapeutic aspects of SHOX haploinsufficiency.
- Published
- 2008
- Full Text
- View/download PDF
50. A very rare cause of dyspnea with a unique presentation on a computed tomography scan of the chest: macrophage activation syndrome.
- Author
-
Brandão-Neto RA, Santana AN, Danilovic DL, Bernardi Fdel C, Barbas CS, and de Mendonça BB
- Subjects
- Aged, Diagnosis, Differential, Humans, Lymphocytes pathology, Male, Syndrome, Dyspnea diagnosis, Lung Diseases, Interstitial diagnosis, Lymphohistiocytosis, Hemophagocytic diagnosis, Macrophage Activation, Tomography, X-Ray Computed methods
- Abstract
Macrophage activation syndrome is a rare and potentially life-threatening disease. It occurs due to immune dysregulation manifested as excessive macrophage proliferation, typically causing hepatosplenomegaly, pancytopenia and hepatic dysfunction. Here, we report an unusual case of macrophage activation syndrome presenting as dyspnea, as well as (reported here for the first time) high resolution computed tomography findings of an excavated nodule, diffuse ground glass opacities and consolidations (mimicking severe pneumonia or alveolar hemorrhage). The patient was successfully treated with human immunoglobulin. We recommend that macrophage activation syndrome be considered in the differential diagnosis of respiratory failure. Rapid diagnosis and treatment are essential to achieving favorable outcomes in patients with this syndrome.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.